1) osteoprotegerin ligand
骨保护素配体
1.
The rumor-necrosis-factor-family molecule osteoprotegerin ligand(OPGL; also known as TRANCE,RANKL and ODF)has been lately identified as a potential osteoclast differentiation factor that distributes in bone,blood and immune system.
肿瘤坏死因子家族成员骨保护素配体(osteoprotegerin ligand，OPGL；又称TRANCE，RANKL，ODF)是近年发现的在动物的骨、血液及免疫系统等处分布的，促进破骨细胞分化的蛋白分子。
2) OPGL
骨保护素配体
1.
Specific inhibition of OPGL expression by RNA interference;
RNAi法特异性抑制骨保护素配体
2.
Osteoprotegerin(OPG) is a physiological cytokine inhibiting bone resorption resulting from osteoclast,while Osteoprotegerin ligand(OPGL) is a cytokine which can directly induce osteoclast differentiation and development as well as mediate function regulation of osteoclast.
骨保护素(OPG)是生理性的抑制破骨细胞性骨吸收的因子,而骨保护素配体(OPGL)是能直接诱导破骨细胞分化发育并参与破骨细胞功能调节的细胞因子。
3) Osteoprotegerin ligand
骨保护素配体(OPGL)
4) receptor activator of nuclear factor kappa B ligand
护骨素配体
1.
Objective To investigate the effect of kdney-tonifying tranditional Chinese medicine,Gu Ling Pian(GLP)on regulating human osteoblasts function and the osteoprotegerin(OPG)/receptor activator of nuclear factor kappa B ligand(RANKL)expression via p38 MAPK pathway in vitro.
采用Western-blot及Real time RT-PCR的方法观察各组成骨细胞护骨素和护骨素配体基因表达和磷酸化p38含量,用MTT法测定各组成骨细胞增殖率,利用茜素红染色法测定矿化结节形成的数量。
5) RANKL
护骨素配体
1.
The expression of the OPG, RANKL and M-CSF mRNA, cell proliferation and formation of mineralized bone nodule, the total protein of p38 and phosphorylated p38, were observed or quantitatively me.
采用Western-blotting及RealtimeRT-PCR方法观察各组成骨细胞护骨素(OPG)、护骨素配体(RANKL)以及巨噬细胞集落刺激因子(M-CSF)基因表达和磷酸化p38含量。
6) Osteoprotegerin/the ligand of osteoprotegerin(OPG/OPGL)
护骨素护骨素配体(OPG/OPGL)
补充资料：胆红素结合Y配体素及Z蛋白
胆红素结合Y配体素及Z蛋白
bilir?ubin binding ligandin Y and Z protein
肝细胞内对胆红素和有机阴离子起运载作用的蛋白质。游离胆红素被肝脏摄取后主要与胆红素结合的Y配体素结合，转运至内质网，进一步与葡萄糖醛酸基移换酶起反应。Z蛋白也有与胆红素结合起同样运载作用。胆红素结合Y配体素及Z蛋白对许多有机阴离子在肝细胞内运送均起作用。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条